AltRx advertises some of the deepest promotional pricing in GLP-1 telehealth — compounded semaglutide from $89/month during its current promotion, with multi-month tiers going lower. Pallas Health takes the opposite pricing posture: a higher sticker with the entire arc — intro, renewal, interval — printed in one sentence. This comparison is really about promotional pricing versus published pricing, and the refund terms underneath each.
AltRx's promotions rotate on short windows, so figures reflect published pricing as of August 2026 — confirm current numbers on both sites before signing up.
The three differences that matter most
- Promo price versus published price. AltRx's $89/month semaglutide and $149/month tirzepatide are promotional rates shown against struck-through list prices of $199 and $299; its multi-month prepay tiers run lower still. What the price becomes at renewal isn't separately published. Pallas's number is the published number: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Tirzepatide injection is $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. With any promotional offer — anywhere — get the renewal rate in writing before you enroll.
- The refund window. Per AltRx's published policy, medication orders are non-refundable once your intake is submitted; refunds apply only to provider-determined medical ineligibility or verified billing errors, and requests must be filed within 28 days of payment. Pallas charges nothing until a clinician prescribes, and you can cancel your plan anytime, self-serve.
- Track record. AltRx is a very young consumer brand — its Better Business Bureau file opened in May 2026 and the company publishes no founding history. Pallas is young too (founded 2026) — the difference is verifiability: Pallas publishes its legal entity and clinical leadership on its site.
About compounded medications
Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. A licensed clinician decides whether a compounded preparation — for example, a dose level or a formulation a brand-name product doesn't offer — is appropriate for you.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Quick comparison
| Pallas Health | AltRx | |
|---|---|---|
| Compounded semaglutide injection | Yes — one all-in price, renewal published | Yes — $89/mo promo (list $199); multi-month tiers to $75/mo |
| Compounded tirzepatide injection | Yes — one all-in price | Yes — $149/mo promo (list $299); tiers to $125/mo |
| FDA-approved brand | Yes — $499 first month, then from $599/mo, cash-pay | Ozempic® $1,149 · Zepbound® $1,249 · Wegovy® $1,579 |
| Membership fee | None | None |
| If a clinician doesn't prescribe | Nothing charged | Refund for medical ineligibility at initial consult |
| Refunds otherwise | Cancel anytime; nothing charged unless prescribed | Orders non-refundable once intake is submitted; 28-day request window |
| States served | All 50 + DC | All 50 |
| Care delivery | 100% online, async in most states | Async or video, per provider and state law |
| Companion app | Free on iOS and Android, no subscription | Not offered |
| Consumer-brand track record | Founded 2026; legal entity and clinical leadership published | BBB file opened May 2026; founding history unpublished |
What AltRx does well
The lowest promo numbers in the category. During its current promotion, $89/month semaglutide — and $75/month on a 12-month prepay — undercut essentially everyone, including Pallas. Shipping is free, there's no membership fee, and it advertises flat pricing across doses. If the promotional number holds at renewal, it's a genuinely cheap program; confirm that in writing.
Named 503A pharmacy partners. AltRx lists its compounding pharmacy partners on its product pages — a transparency point in its favor.
What Pallas does differently
Published pricing you can hold us to. Every Pallas surface states the intro, the renewal amount, the interval, and the per-month average in one sentence — $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. — flat at every dose. The compounded plans are compounded semaglutide and compounded tirzepatide injections, one price with clinician care included. No struck-through list prices, no time-boxed banners, no checkout reveal.
Charged only if prescribed. Nothing is charged until a clinician prescribes. Cancel anytime, no windows to hit, no 28-day filing deadline. If your plans change, the terms work in your favor rather than against the clock.
Self-service. A self-serve portal, anytime provider messaging, and the free Pallas companion app (iOS and Android). Whatever platform you consider, run the same checks: LegitScript status, clinician licensure in your state, and US-licensed pharmacy sourcing.
Brand-name breadth. Pallas dispenses all four FDA-approved GLP-1 brands cash-pay, $499 for the first month and then from $599/month — below AltRx's listed brand prices — with no membership on any tier.
Who should pick which
AltRx may fit if:
- The promotional price is your deciding factor and you've confirmed, in writing, what renewal costs
- You're comfortable with orders being non-refundable once your intake is submitted
Pallas is probably the better fit if:
- You want the ongoing price published before you start — and flat at every dose
- You want nothing charged unless a clinician prescribes, and cancel-anytime terms
- Verifiable certification and named clinical leadership matter to your decision
- You may want brand-name medication at the lower cash price
Switching between them
Bring your medication name, current dose, and titration history. A Pallas clinician picks up from your current dose — no restart of titration unless you've been off medication for more than four weeks. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.
Bottom line: AltRx competes on the promotional number — the deepest in the category right now — with refund terms that close once your intake is submitted and a consumer track record that's only months old. Pallas competes on the published number: the full price arc stated up front, flat at every dose, nothing charged unless a clinician prescribes, cancel anytime, verifiable certification, and cheaper brand-name access. Decide which of those two postures you want to buy healthcare from — and whichever you pick, get the renewal rate in writing.
